141 related articles for article (PubMed ID: 19576638)
21. Australian Meningococcal Surveillance Programme annual report, 2015.
Lahra MM; Enriquez RP;
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
[TBL] [Abstract][Full Text] [Related]
22. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
[No Abstract] [Full Text] [Related]
23. Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.
Ibarz-Pavón AB; Lemos AP; Gorla MC; Regueira M; ; Gabastou JM
PLoS One; 2012; 7(8):e44102. PubMed ID: 22952888
[TBL] [Abstract][Full Text] [Related]
24. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
25. Molecular Characterization of Invasive Isolates of Neisseria meningitidis in Casablanca, Morocco.
Razki A; Hong E; Zerouali K; Belabbes H; Aitmouss K; Terrade A; Zaki B; Deghmane AE; Elmdaghri N; Taha MK
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743304
[TBL] [Abstract][Full Text] [Related]
26. Temporal variations in the serogroup distribution of invasive meningococcal disease in Quebec, Canada, due to emerging unique clade of serogroup Y strain belonging to the Sequence Type-23 clonal complex.
Tsang RSW; Deceuninck G; Meilleur C; Zhou J; Lefebvre B; De Wals P
J Infect; 2024 Jun; 88(6):106163. PubMed ID: 38670267
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Tsang RS; Squires SG; Tam TW
Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
[TBL] [Abstract][Full Text] [Related]
28. Meningococcal serotype Y myopericarditis.
Nkosi J; Thakrar A; Kumar K; Ahmadie R; Fang T; Lytwyn M; Francis A; Kasper K; Kirkpatrick I; Jassal DS
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):223-7. PubMed ID: 19026509
[TBL] [Abstract][Full Text] [Related]
29. Meningococcal disease due to serogroup Y in Scotland, 1992-1999.
Clarke SC; Reid J; Thom L; Denham BC; Edwards GF
Br J Biomed Sci; 2001; 58(1):17-9. PubMed ID: 11284218
[TBL] [Abstract][Full Text] [Related]
30. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
31. [Laboratory surveillance for invasive meningococcal disease in Chile, 2006-2012].
Araya P; Díaz J; Seoane M; Fernández J; Terrazas S; Canals A; Vaquero A; Barra G; Hormazábal JC; Pidal P; Valenzuela MT
Rev Chilena Infectol; 2014 Aug; 31(4):377-84. PubMed ID: 25327189
[TBL] [Abstract][Full Text] [Related]
32. Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006.
Simões MJ; Cunha M; Almeida F; Furtado C; Brum L
Epidemiol Infect; 2009 Feb; 137(2):161-5. PubMed ID: 18667108
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.
Lemos AP; Harrison LH; Lenser M; Sacchi CT
J Infect; 2010 Mar; 60(3):209-17. PubMed ID: 20056121
[TBL] [Abstract][Full Text] [Related]
34. Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002.
Whitney AM; Coulson GB; von Gottberg A; Block C; Keller N; Mayer LW; Messonnier NE; Klugman KP
J Clin Microbiol; 2009 Sep; 47(9):2787-93. PubMed ID: 19571028
[TBL] [Abstract][Full Text] [Related]
35. Typing of Neisseria meningitidis isolates from patients with invasive disease by molecular analysis of porin genes.
Stefanelli P; Fazio C; Mastrantonio P
New Microbiol; 2001 Apr; 24(2):149-55. PubMed ID: 11346298
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.
Vespa Presa J; Abalos MG; Sini de Almeida R; Cane A
Int J Infect Dis; 2019 Aug; 85():37-48. PubMed ID: 31085314
[TBL] [Abstract][Full Text] [Related]
37. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children.
Levy C; Taha MK; Weil Olivier C; Quinet B; Lecuyer A; Alonso JM; Aujard Y; Bingen E; Cohen R;
Pediatr Infect Dis J; 2010 Jul; 29(7):618-23. PubMed ID: 20168263
[TBL] [Abstract][Full Text] [Related]
38. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012.
Säll O; Stenmark B; Glimåker M; Jacobsson S; Mölling P; Olcén P; Fredlund H
Epidemiol Infect; 2017 Jul; 145(10):2137-2143. PubMed ID: 28478773
[TBL] [Abstract][Full Text] [Related]
39. Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003.
Law DK; Stoltz J; Henderson AM; Tsang RS
Can J Microbiol; 2005 Jul; 51(7):523-30. PubMed ID: 16175200
[TBL] [Abstract][Full Text] [Related]
40. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
